The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Solar Fund Regulatory News (FSFL)

Share Price Information for Foresight Solar Fund (FSFL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 90.50
Bid: 90.40
Ask: 90.70
Change: 0.00 (0.00%)
Spread: 0.30 (0.332%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 90.50
FSFL Live PriceLast checked at -
Foresight Solar Fund is an Investment Trust

To provide investors with a sustainable, progressive quarterly dividend and enhanced capital value, through investment in ground based solar assets predominantly located in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

26 Jun 2019 09:21

RNS Number : 4742D
Foresight Solar Fund Limited
26 June 2019
 

26 June 2019

Foresight Solar Fund Limited

(the "Company")

Results of Annual General Meeting in accordance with LR 9.6.18

The Company is pleased to announce that, at the AGM held at 9:30 a.m. on Monday, 25 June 2019, each of the Resolutions were duly passed without amendment.

In accordance with LR 9.6.18, details of those resolutions passed are as follows:

Resolution

Votes For (including discretion)

% Votes For (including discretion)

Votes Against

% Votes Against

Votes Withheld

Total Votes Cast (excl. Votes Withheld)

Votes Cast as % of Issued Share Capital

RES:001

319,850,362

100.00

0

0.00

0

319,850,362

58.27%

RES:002

319,826,062

100.00

15,000

0.00

9,300

319,841,062

58.27%

RES:003

319,825,563

100.00

15,499

0.00

9,300

319,841,062

58.27%

RES:004

312,585,713

100.00

2,500

0.00

7,262,148

312,588,213

56.94%

RES:005

319,850,362

100.00

0

0.00

0

319,850,362

58.27%

RES:006

319,850,362

100.00

0

0.00

0

319,850,362

58.27%

RES:007

318,829,562

100.00

2,000

0.00

1,018,800

318,831,562

58.08%

RES:008

279,854,422

87.50

39,995,939

12.56

0

319,850,361

58.27%

RES:009

319,664,774

99.94

176,087

0.06

9,500

319,840,861

58.27%

RES:010

312,539,942

97.71

7,310,419

2.29

0

319,850,361

58.27%

RES:011

319,839,230

100.00

1,632

0.00

9,500

319,840,862

58.27%

RES:012

319,823,873

100.00

4,689

0.00

21,800

319,828,562

58.26%

RES:013

319,842,673

100.00

4,689

0.00

3,000

319,847,362

58.27%

RES:014

319,842,673

100.00

4,689

0.00

3,000

319,847,362

58.27%

RES:015

319,843,862

100.00

3,500

0.00

3,000

319,847,362

58.27%

 

*A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "for" or "against" the Resolution.

 The full wording of these resolutions can be found below:-

 

Ordinary Resolutions

 

1) To receive and adopt the Company's annual accounts for the financial year ended 31 December 2017 together with the directors' report and auditors' report on those accounts.

 

2) To approve the directors' remuneration report (excluding the directors' remuneration policy, set out on page 49 of the directors' remuneration report), as set out in the Company's annual report and accounts for the financial year ended 31 December 2017.

 

3) To approve the directors' remuneration policy, as set out on page 49 of the directors' remuneration report, which takes effect immediately after the end of annual general meeting.

 

4) To re-appoint KPMG LLP as the Company's auditor to hold office from the conclusion of this meeting until the conclusion of the next annual general meeting at which accounts are laid before the Company.

 

5) To authorise the directors of the Company to determine the auditor's remuneration.

 

6) To approve the Dividend Policy.

 

7) To elect Monique O'Keefe to the Board of the Company following her appointment under article 101 of the Company's articles of association (the "Articles").

 

8) To reappoint Alexander Ohlsson as a director of the Company.

 

9) To reappoint Chris Ambler as a director of the Company.

 

10) To reappoint Peter Dicks as a director of the Company.

 

11) THAT, subject to resolution 12 below being passed, in addition to any existing power and authority granted to the Directors, the Directors of the Company be and are hereby authorised pursuant to Article 153.1 to exercise the power conferred on them by Article 152(b) of the Articles to offer holders of ordinary shares in the capital of the Company the right to elect to receive ordinary shares credited as fully paid, instead of cash in respect of the whole (or some part to be determined by the Directors) of dividends declared, made or paid during the period starting with the date of this Resolution and ending at the conclusion of the third annual general meeting of the Company following the date of this Resolution and shall be permitted to do all acts and things required or permitted to be done in accordance with the Articles in connection therewith.

 

Special Resolutions

 

12) THAT the following alterations be made to the Articles:(a) In respect of Article 10.1.6, the cross-reference to Article 150 be deleted and replaced with a cross-reference to Article 152; and

(b) In respect of Article 152, the words 'at par' in Articles 152(a) and 152(b) be deleted and replaced with the words 'at stated value'.

13) THAT the Company be and is hereby generally and unconditionally authorised, pursuant to and in accordance with Article 57 of the Companies (Jersey) Law, 1991 (as amended) (the "Law") to make market purchases of its own ordinary shares of no par value in the capital of the Company (the "Ordinary Shares") on such terms and in such manner as the directors of the Company shall from time to time determine, subject always to the terms of any class rights in the articles of association and provided that:

 

a) the maximum aggregate number of Ordinary Shares hereby authorised to be purchased shall be such number as represents 14.99 per cent of the aggregate number of Ordinary Shares in issue as at 25 June 2019;

 

b) the minimum price which may be paid for an Ordinary Share shall be £0.01;

 

c) the maximum price exclusive of any expenses which may be paid for an Ordinary Share is an amount equal to the higher of (i) 105% of the average of the middle market quotations for an Ordinary Share (as derived from the Daily Official List of the London Stock Exchange plc) for the five business days immediately preceding the date on which such Ordinary Share is contracted to be purchased; and (ii) the higher of the last independent trade and the highest current independent bid on the trading venue on which the purchase is carried out.

 

d) the authority hereby conferred is in addition to all and any authorities in place in respect of market purchases by the Company and shall expire at the conclusion of the Company's next annual general meeting or on the date falling 18 months from the date of the passing of this resolution, whichever is earlier, unless previously revoked, varied or renewed by the Company in general meeting;

 

e) the Company may at any time prior to the expiry of such authority make a contract or contracts to purchase Ordinary Shares under such authority which will or might be completed or executed wholly or partly after the expiration of such authority and may make a purchase of Ordinary Shares in pursuance of any such contract or contracts; and

 

f) the directors of the Company provide a statement of solvency in accordance with the Articles 55 and 57 of the Law.

 

14) THAT, subject to resolution 13 ("Resolution 13") above being passed, the Company be and is hereby generally and unconditionally authorised to cancel any shares it repurchases pursuant to Resolution 13 or pursuant to Article 58A(1)(b) of the Law to hold such shares it repurchases pursuant to Resolution 13 as treasury shares to be dealt with in accordance with the provisions of the Law as the directors of the Company see fit.

 

15) THAT, in addition to any existing power and authority granted to the Directors, the Directors of the Company be and are hereby generally empowered to allot Ordinary Shares of no par value carrying the rights, privileges and subject to the restrictions attached to the Ordinary Shares as set out in the articles of association of the Company (the "Ordinary Shares") or to grant rights to subscribe for or, to convert securities into Ordinary Shares (''equity securities''), including the allotment and grant of rights to subscribe for, or to convert securities into or the sale of, Ordinary Shares held by the Company as treasury shares in each case for cash as if any pre-emption rights in relation to the issue of or sale of shares, as set out in Article 10.2 of the articles of association of the Company and in the Listing Rules made by the Financial Conduct Authority under Part VI of the Financial Services and Markets Act 2000 (as amended), did not apply to any such allotment of or grant of rights to subscribe for or to convert into equity securities or sale, provided that this power:

 

a) shall expire at the conclusion of the Company's next annual general meeting or on the date falling 15 months after the passing of this resolution, whichever is earlier, save that the Company may, before such expiry, make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Directors may allot equity securities in pursuance of any such offer or agreement as if the power conferred hereby had not expired; and

 

b) shall be limited to the allotment of up to 44,995,209 Ordinary Shares of no par value (representing as at 21 February 2018 approximately 10% per cent. of the issued share capital of the Company).

 

ENDS

 

For further information, please contact:

Foresight Group

Joanna Andrews

 

 +44 (0) 20 3763 6951

JTC (Jersey) Limited

 +44 (0) 1534 700 000

Christopher Gibbons

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGSEISAMFUSEFM
Date   Source Headline
18th Aug 20227:00 amRNSNotice of Results
1st Aug 20223:08 pmRNSCancellation of Scrip Offer
1st Aug 20227:00 amRNSQ2 2022 Net Asset Value and BSS Acquisition
27th Jul 20225:30 pmRNSUltra Electronics Holdings
16th Jun 20227:00 amRNSDeclaration of Dividend
15th Jun 20224:28 pmRNSResults of 2022 Annual General Meeting
13th Jun 20224:24 pmRNSDirector Shareholding
25th May 20224:17 pmRNSNotice of AGM - Replacement
25th May 20227:00 amRNSNotice of AGM
25th May 20227:00 amRNSProposed change to Investment Policy & AGM Notice
16th May 20221:43 pmRNSCancellation of Scrip Dividend
3rd May 20227:00 amRNSQ1 2022 Net Asset Value and Operational Update
29th Apr 20225:12 pmRNSScrip Share Price
11th Apr 20227:00 amRNSOakey 1 and Longreach Portfolio Refinancing
29th Mar 20227:00 amRNSForesight Solar - Project Lorca Debt Refinancing
9th Mar 20227:00 amRNSAnnual Results to 31 December 2021
3rd Mar 20225:25 pmRNSDirector Shareholding
28th Feb 20227:00 amRNSSustainability Linked Revolving Credit Facility
21st Feb 20227:00 amRNSNotice of Results
10th Feb 20227:00 amRNSQ4 2021 NAV, Scrip Dividend and Operational Update
3rd Feb 202211:16 amRNSScrip Share Price
2nd Feb 20227:00 amRNSHolding(s) in Company
4th Jan 20227:00 amRNSAcquisition of stakes in Australian solar farms
22nd Dec 20216:20 pmRNSHolding(s) in Company
13th Dec 20217:00 amRNSNew PPA for 98.5MW Spanish solar portfolio
6th Dec 20217:00 amRNSDividend Declaration
30th Nov 202111:30 amRNSTotal Voting Rights
23rd Nov 20219:48 amRNSListing pursuant to Scrip Alternative and TVR
5th Nov 20215:30 pmRNSScrip Share Price
2nd Nov 20217:00 amRNSQ3 2021 NAV, Operational and Gearing Update
16th Sep 20217:00 amRNSInterim Results to 30 June 2021
31st Aug 20213:12 pmRNSTotal Voting Rights
25th Aug 20217:00 amRNSListing pursuant to Scrip Alternative and TVR
18th Aug 20217:00 amRNSNotice of Results
5th Aug 20214:46 pmRNSScrip Share Price
3rd Aug 202111:36 amRNSDirector Declaration
2nd Aug 20217:00 amRNSQ2 2021 Net Asset Value and Operational Update
21st Jul 20217:00 amRNSDeclaration of Dividend
28th Jun 20213:59 pmRNSHolding(s) in Company
23rd Jun 20219:00 amRNSChange in Board committee composition
18th Jun 20214:41 pmRNSSecond Price Monitoring Extn
18th Jun 20214:35 pmRNSPrice Monitoring Extension
16th Jun 20212:06 pmRNSResults of 2021 Annual General Meeting
7th Jun 202110:00 amRNSHolding(s) in Company
2nd Jun 20214:00 pmRNSDirector Shareholding
25th May 20214:09 pmRNSListing pursuant to Scrip Alternative and TVR
25th May 20217:00 amRNSNotice of 2021 Annual General Meeting
17th May 20217:00 amRNSQ1 2021 Net Asset Value
12th May 20217:00 amRNSScrip Share Price
11th May 20216:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.